Jun Xia

assistant professor

Texas A&M University
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (4)

Year:

2026

Background: Clinical, molecular, and genetic epidemiology studies displayed remarkable differences between ever- and never-smoking lung cancer. Methods: We conducted a stratified multi-population (European, East Asian, and African descent) association study on 44,823 ever-smokers and 20,074 never-smokers to identify novel variants that were missed in the non-stratified analysis. Functional analysis including expression quantitative trait loci (eQTL) colocalization and DNA damage assays, and annotation studies were conducted to evaluate the functional roles of the variants. We further evaluated the impact of smoking quantity on lung cancer risk for the variants associated with ever-smoking lung cancer. Results: Five novel independent loci, GABRA4 , intergenic region 12q24.33 , LRRC4C , LINC01088, and LCNL1 were identified with the association at two or three populations ( P −8 ). Further functional analysis provided multiple lines of evidence suggesting the variants affect lung cancer risk through excessive DNA damage ( GABRA4 ) or cis -regulation of gene expression ( LCNL1 ). The risk of variants from 12 independent regions, including the well-known CHRNA5 , associated with ever-smoking lung cancer was evaluated for never-smokers, light-smokers (packyear ≤ 20), and moderate-to-heavy-smokers (packyear > 20). Different risk patterns were observed for the variants among the different groups by smoking behavior. Conclusions: We identified novel variants associated with lung cancer in only ever- or never-smoking groups that were missed by prior main-effect association studies. Impact: Our study highlights the genetic heterogeneity between ever- and never-smoking lung cancer and provides etiologic insights into the complicated genetic architecture of this deadly cancer.

Year:

2024

Background: Clinical, molecular, and genetic epidemiology studies displayed remarkable differences between ever- and never-smoking lung cancer. Methods: We conducted a stratified multi-population (European, East Asian, and African descent) association study on 44,823 ever-smokers and 20,074 never-smokers to identify novel variants that were missed in the non-stratified analysis. Functional analysis including expression quantitative trait loci (eQTL) colocalization and DNA damage assays, and annotation studies were conducted to evaluate the functional roles of the variants. We further evaluated the impact of smoking quantity on lung cancer risk for the variants associated with ever-smoking lung cancer. Results: Five novel independent loci, GABRA4 , intergenic region 12q24.33 , LRRC4C , LINC01088, and LCNL1 were identified with the association at two or three populations ( P −8 ). Further functional analysis provided multiple lines of evidence suggesting the variants affect lung cancer risk through excessive DNA damage ( GABRA4 ) or cis -regulation of gene expression ( LCNL1 ). The risk of variants from 12 independent regions, including the well-known CHRNA5 , associated with ever-smoking lung cancer was evaluated for never-smokers, light-smokers (packyear ≤ 20), and moderate-to-heavy-smokers (packyear > 20). Different risk patterns were observed for the variants among the different groups by smoking behavior. Conclusions: We identified novel variants associated with lung cancer in only ever- or never-smoking groups that were missed by prior main-effect association studies. Impact: Our study highlights the genetic heterogeneity between ever- and never-smoking lung cancer and provides etiologic insights into the complicated genetic architecture of this deadly cancer.

Year:

2024

Year:

2023

Collaborators (33)

Rayjean Hung

University of Toronto

CANADA
View details

Susan M. Rosenberg

Ben F Love Chair in Cancer Research and professor

Baylor College of Medicine

UNITED STATES
View details

Yanhong Liu

Associate Professor

Baylor College of Medicine

UNITED STATES
View details

Yun-Chul Hong

Seoul National University College of Medicine

SOUTH KOREA
View details

Sanjay Shete

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

David Christiani

Harvard University

UNITED STATES
View details

Adonina Tardon

Coordinating Professor of the Doctoral Program in Medicine and Epidemiology

Universidad Antonio de Nebrija

SPAIN
View details

Christopher I. Amos

Associate Director for Population and Data Science

Baylor College of Medicine

UNITED STATES
View details

Melinda Aldrich

Vanderbilt University Medical Center

UNITED STATES
View details

Susan Pinney

University of Cincinnati

UNITED STATES
View details

Stig E. Bojesen

Copenhagen University Hospital

DENMARK
View details

Saurabh Pratap Singh

Senior Scientist

University of Washington

UNITED STATES
View details

Chao Cheng

Associate Professor

Baylor College of Medicine

UNITED STATES
View details

Ann G. Schwartz

Wayne State University School of Medicine

UNITED STATES
View details

Diptasri Mandal

Professor (Tenured)

Louisiana State University Health Sciences Center

UNITED STATES
View details

Kristen S. Purrington

Associate Professor

Wayne State University School of Medicine

UNITED STATES
View details

John Field

Professor

University of Liverpool

UNITED KINGDOM
View details

Nima Mosammaparast

Washington University in St. Louis

UNITED STATES
View details

Yohan Bossé

Laval University

CANADA
View details

Ryan Sun

Assistant Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Joan Bailey-Wilson

Co-Branch Chief

National Human Genome Research Institute

UNITED STATES
View details

Philip Lazarus

Professor

University at Buffalo

UNITED STATES
View details

Matthew Schabath

Program Leader and Senior Member

H Lee Moffitt Cancer Center and Research Institute

UNITED STATES
View details

Loic Le Marchand

Professor

University of Hawaii

UNITED STATES
View details

Mikael Johansson

Ass professor

Umea University

SWEDEN
View details

Michael Peter Alan Davies

Roy Castle Lung Cancer Foundation Senior Research Fellow

University of Liverpool

UNITED KINGDOM
View details

Jian-Rong Li

Assistant Professor

Chang Gung University

TAIWAN
View details

Jinyoung Byun

Associate Professor

University of New Mexico

UNITED STATES
View details

Mattias Johansson

Scientist

International Agency for Research on Cancer

FRANCE
View details

Susanne Arnold

University of Kentucky

UNITED STATES
View details

Geoffrey Liu

The M. Qasim Choksi Chair in Lung Cancer Translational Research

University of Toronto

CANADA
View details

Ping Yang

Professor

Mayo Clinic Arizona

UNITED STATES
View details

Chu Chen

Full Member

Fred Hutchinson Cancer Research Center

UNITED STATES
View details